Responses
Clinical/translational cancer immunotherapy
Short report
Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
Compose a Response to This Article
Other responses
No responses have been published for this article.
